Precedex is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Dexmedetomidine Hydrochloride.
| Product ID | 0409-1174_03c3298a-846b-4b32-b9cf-fa7fc49d2c77 |
| NDC | 0409-1174 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Precedex |
| Generic Name | Dexmedetomidine Hydrochloride |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2022-03-07 |
| Marketing Category | NDA / |
| Application Number | NDA021038 |
| Labeler Name | Hospira, Inc. |
| Substance Name | DEXMEDETOMIDINE HYDROCHLORIDE |
| Active Ingredient Strength | 4 ug/mL |
| Pharm Classes | Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-03-07 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0404-9938 | PRECEDEX | DEXMEDETOMIDINE HYDROCHLORIDE |
| 0409-0155 | Precedex | DEXMEDETOMIDINE HYDROCHLORIDE |
| 0409-1174 | Precedex | DEXMEDETOMIDINE HYDROCHLORIDE |
| 0409-1434 | Precedex | DEXMEDETOMIDINE HYDROCHLORIDE |
| 0409-1454 | Precedex | DEXMEDETOMIDINE HYDROCHLORIDE |
| 0409-1638 | Precedex | DEXMEDETOMIDINE HYDROCHLORIDE |
| 0409-1660 | Precedex | DEXMEDETOMIDINE HYDROCHLORIDE |
| 52584-638 | PRECEDEX | PRECEDEX |
| 0143-9525 | Dexmedetomidine Hydrochloride | Dexmedetomidine Hydrochloride |
| 0143-9526 | Dexmedetomidine Hydrochloride | Dexmedetomidine Hydrochloride |
| 0338-9555 | DEXMEDETOMIDINE HYDROCHLORIDE | DEXMEDETOMIDINE HYDROCHLORIDE |
| 0338-9557 | DEXMEDETOMIDINE HYDROCHLORIDE | DEXMEDETOMIDINE HYDROCHLORIDE |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PRECEDEX 75383541 2419482 Live/Registered |
Orion Corporation 1997-11-03 |
![]() PRECEDEX 75197776 not registered Dead/Abandoned |
Orion Corporation 1996-11-13 |